AKRO - Akero Therapeutics, Inc.

QQQ $ 598.23 $ -2.23 (-0.37 %)

DIA $ 458.84 $ -3.15 (-0.68 %)

SPY $ 658.90 $ -4.53 (-0.68 %)

TLT $ 91.49 $ 0.68 (0.75 %)

GLD $ 401.79 $ 9.06 (2.34 %)

Previous Close

$ 53.66

Open

$ 53.74

Bid

$ 53.52 x 1,000

Ask

$ 53.80 x 5

Day's Range

$ 53.60 - $ 53.87

52 Week Range

$ 21.34 - $ 58.40

Volume

2,238,594

Average Volume

Market Cap

4.29B

Beta (5Y Monthly)

$ 0.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-17-2023	12-31-2022	10-K
12	11-04-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	02-25-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-13-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-16-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-13-2020	03-31-2020	10-Q
23	03-16-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-12-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

this-keysight-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday

This Keysight Analyst Is No Longer Bullish...
10/10/2025 13:53:02

Wolfe Research Downgrades Akero Therapeuti...
10/10/2025 11:27:50

Wolfe Research analyst Andy Chen downgrades Akero Therapeutics (NASDAQ:AKRO) from Outperform to Peer Perform.

HC Wainwright & Co. Downgrades Akero Thera...
10/10/2025 10:56:38

HC Wainwright & Co. analyst Andrew S. Fein downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Neutral and lowers th...

Akero Therapeutics Says If Deal Terminated...
10/09/2025 20:50:12

-SEC Filing

Jefferies Downgrades Akero Therapeutics to...
10/09/2025 16:15:35

Jefferies analyst Andrew Tsai downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Hold and lowers the price target from ...

Canaccord Genuity Downgrades Akero Therape...
10/09/2025 15:38:55

Canaccord Genuity analyst Edward Nash downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Hold and lowers the price targ...

tilray-brands-posts-upbeat-results-joins-byrna-technologies-delta-air-lines-and-other-big-stocks-moving-higher-on-thursday

Tilray Brands Posts Upbeat Results, Joins ...
10/09/2025 14:14:52

novo-nordisk-to-acquire-liver-disease-focused-akero-therapeutics-for-around-5-billion

Novo Nordisk To Acquire Liver Disease Focu...
10/09/2025 13:10:21

Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabo...

12 Health Care Stocks Moving In Thursday's...
10/09/2025 12:07:59

Novo Nordisk To Acquire Akero Therapeutics...
10/09/2025 10:03:27

Akero Therapeutics To Present 96-Week Phas...
10/07/2025 11:10:09

HC Wainwright & Co. Assumes Akero Therapeu...
09/04/2025 11:14:25

HC Wainwright & Co. analyst Andrew S. Fein assumes Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and announces Pric...

Akero Publishes 96-Week Phase 2b HARMONY T...
08/14/2025 22:31:16

Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing transformational treatments for patients with serio...

Akero Therapeutics Q2 EPS $(0.86) Beats $(...
08/08/2025 11:18:02

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(...

this-aerovironment-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This AeroVironment Analyst Begins Coverage...
08/04/2025 15:30:00

TD Cowen Initiates Coverage On Akero Thera...
08/04/2025 11:38:45

TD Cowen analyst Ritu Baral initiates coverage on Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and announces Price Tar...

B of A Securities Maintains Buy on Akero T...
05/27/2025 15:20:22

B of A Securities analyst Alexandria Hammond maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and raises the price targ...

10 Health Care Stocks With Whale Alerts In...
05/20/2025 17:35:25

Watching Akero Therapeutics; Shares Spike ...
05/20/2025 17:29:40

Citigroup Maintains Buy on Akero Therapeut...
05/13/2025 19:16:38

Citigroup analyst Jonathan Woo maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and lowers the price target from $80 to...